Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Baxter International Inc (NYSE:BAX)

52.02
Delayed Data
As of Mar 24
 +0.33 / +0.64%
Today’s Change
39.90
Today|||52-Week Range
52.33
+17.32%
Year-to-Date
MedTech Long-Term Prospects Impress: Which Stocks to Buy?
Mar 22 / Zacks.com - Paid Partner Content
Baxter's Chart Is Still Bullish
Mar 20 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close51.69
Today’s open51.72
Day’s range51.58 - 52.19
Volume2,655,479
Average volume (3 months)3,246,151
Market cap$28.2B
Dividend yield1.00%
Data as of 4:05pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)+410.02%
Earnings growth (this year)+10.47%
Earnings growth (next 5 years)+11.30%
Revenue growth (last year)+1.96%
P/E ratio5.8
Price/Sales2.40
Price/Book3.39

Competitors

 Today’s
change
Today’s
% change
INCYIncyte Corp+0.67+0.48%
ALXNAlexion Pharmaceutic...-1.00-0.83%
ZTSZoetis Inc+0.05+0.09%
VRTXVertex Pharmaceutica...+0.93+1.04%
Data as of 4:14pm ET, 03/24/2017

Financials

Next reporting dateApril 20, 2017
EPS forecast (this quarter)$0.51
Annual revenue (last year)$10.2B
Annual profit (last year)$4.9B
Net profit margin48.86%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Joe Almeida
Vice President-
Operations
Scott Pleau
Corporate headquarters
Deerfield, Illinois

Forecasts


Search for Jobs